Covid-19 : a project of the vaccine appears to trigger an immune response

the first phase of The test by the laboratory Moderna revealed an immune response in eight people, but the full results of the trial are not yet known. The u.s

the first phase of The test by the laboratory Moderna revealed an immune response in eight people, but the full results of the trial are not yet known.

The u.s. laboratory Moderna has announced that Monday, or “acting positive” of the initial phase of clinical trials of its proposed vaccine against the new coronavirus, on a small number of volunteers.

READ ALSO >> Where is the race to the vaccine against the coronavirus ?

The vaccine, called mRNA-1273, seemed to elicit an immune response in eight persons, to whom it was administered, of the same magnitude as what we observe among those who have been naturally contaminated with the virus, according to a press release from the laboratory. The full results of the phase 1 trial, the first in the development of a vaccine, and that includes 45 participants in this case are not yet known.

Your support is essential. Subscribe for $ 1 support Us

phase 2 of The test soon to be launched

“These data interim phase 1, although preliminary, demonstrate that immunization with mRNA-1273 triggers an immune response similar in magnitude as that caused by a natural infection,” said Tal Zaks, medical director of Moderna.

READ ALSO >> “The vaccine will kill you” : the offensive digital antivax at the time of the Covid-19

The clinical trial is conducted by the national Institutes of health (NIH), and the u.s. government has invested nearly half a billion dollars in the project of Moderna. Three groups of 15 patients received three different doses of the vaccine, once or twice.

phase 2, a larger number of people, should begin in the near future, and according to Moderna, phase 3, the last and most important to validate the effectiveness of the vaccine, expected to begin in July. Tests conducted on mice have separately shown that the vaccine prevented the virus to replicate in their lungs, according to the company.

Read our complete file

LIVE. 1701 patients in the intensive care unit in France, 74 died in the hospital in 24 hours Iran : recovery forced, despite the pandemic Coronavirus : the launch of two studies on the persistence and resurgence of symptoms

“The team of Moderna continues to focus on the launch of the vital test of phase 3 in July as quickly and safely as possible,” said the boss of Moderna, Stéphane Bancel.

Date Of Update: 22 May 2020, 14:58

Categories: Optical Illusion
Source: newstars.edu.vn

Leave a Comment